Travere Therapeutics, Inc. (TVTX)
52.12
+0.08
(+0.16%)
USD |
NASDAQ |
Oct 09, 16:00
52.17
+0.04
(+0.09%)
After-Hours: 20:00
Travere Therapeutics EPS Diluted (Quarterly) : -0.3722 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3722 |
| March 31, 2026 | -0.3984 |
| December 31, 2025 | -0.2435 |
| September 30, 2025 | 0.2505 |
| June 30, 2025 | -0.1434 |
| March 31, 2025 | -0.4666 |
| December 31, 2024 | -0.7252 |
| September 30, 2024 | -0.7047 |
| June 30, 2024 | -0.9085 |
| March 31, 2024 | -1.764 |
| December 31, 2023 | -1.18 |
| September 30, 2023 | -0.9856 |
| June 30, 2023 | -1.127 |
| March 31, 2023 | -1.266 |
| December 31, 2022 | -1.025 |
| September 30, 2022 | -1.088 |
| June 30, 2022 | -1.053 |
| March 31, 2022 | -1.203 |
| December 31, 2021 | -0.837 |
| September 30, 2021 | -0.5861 |
| June 30, 2021 | -0.6441 |
| March 31, 2021 | -0.9573 |
| December 31, 2020 | -2.372 |
| September 30, 2020 | -0.4428 |
| June 30, 2020 | -0.5823 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0185 |
| December 31, 2019 | -0.7033 |
| September 30, 2019 | -0.8497 |
| June 30, 2019 | -0.9224 |
| March 31, 2019 | -0.9895 |
| December 31, 2018 | -0.1806 |
| September 30, 2018 | -1.34 |
| June 30, 2018 | -0.56 |
| March 31, 2018 | -0.4634 |
| December 31, 2017 | -0.45 |
| September 30, 2017 | -0.46 |
| June 30, 2017 | -0.34 |
| March 31, 2017 | -0.32 |
| December 31, 2016 | -0.2634 |
| September 30, 2016 | -1.00 |
| June 30, 2016 | -0.37 |
| March 31, 2016 | -0.08 |
| December 31, 2015 | -0.0681 |
| September 30, 2015 | 1.78 |
| June 30, 2015 | -0.73 |
| March 31, 2015 | 1.305 |
| December 31, 2014 | -1.10 |
| September 30, 2014 | -0.89 |
| June 30, 2014 | -0.90 |
| March 31, 2014 | -3.03 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 0.0495 |
| BioMarin Pharmaceutical, Inc. | 0.2302 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| Viridian Therapeutics, Inc. | -1.178 |
| Krystal Biotech, Inc. | 1.786 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.80M |
| Revenue (Quarterly) | 169.58M |
| Total Expenses (Quarterly) | 204.38M |
| Enterprise Value | 5.037B |
| Gross Profit Margin (Quarterly) | 96.22% |
| Profit Margin (Quarterly) | -20.52% |
| Earnings Yield | -1.46% |
| Normalized Earnings Yield | -0.8904 |